Association of controlled attenuation parameter (CAP) and HbA1c in patients with fatty liver
Zeitschrift für Gastroenterologie(2016)
Abstract
Background and aim: Chronic liver diseases and serum glycosylated hemoglobin (HbA1c) levels are linked to one another through the metabolic syndrome. Our aim now was to analyze for the first time the potential association between hepatic steatosis, as determined quantitatively with the controlled attenuation parameter (CAP), and HbA1c.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined